Physician profile
Ellen Gutkin
NPI 1205098795
$5,436.33
in general payments reported to CMS, 2019-2025
18 companies · $322 in 2025
The $322 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,428 · 2020: $499 · 2021: $500 · 2022: $1,469 · 2023: $811 · 2024: $408 · 2025: $322.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,541.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,541.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,519.91 | 2019-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $693.11 | 2019-2024 | Xifaxan |
| Pfizer INC. | $571.35 | 2019-2025 | |
| Janssen Biotech, INC. | $550.82 | 2019-2025 | Stelara, Tremfya |
| Takeda Pharmaceuticals U.S.A., INC. | $475.10 | 2019-2023 | Entyvio |
| Intercept Pharmaceuticals, INC. | $134.59 | 2019-2023 | Ocaliva |
| Ardelyx, INC. | $112.42 | 2022-2023 | Ibsrela |
| Shire North American Group INC | $84.96 | 2019 | |
| Allergan, INC. | $61.13 | 2019 | |
| Gilead Sciences, INC. | $39.22 | 2021 | |
| Ironwood Pharmaceuticals, INC | $38.64 | 2021-2022 | |
| Daiichi Sankyo INC. | $34.56 | 2019 | |
| Celgene Corporation | $23.42 | 2023 | Zeposia |
| Concordia Pharmaceuticals INC. | $22.12 | 2019 | |
| Nestle Healthcare Nutrition INC. | $19.43 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $19.14 | 2019 | |
| Alnylam Pharmaceuticals INC. | $18.75 | 2023 | Givlaari |
| Genzyme Corporation | $17.66 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ellen Gutkin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.